User profiles for Joseph C Ahn
 | Joseph C. AhnMayo Clinic, Rochester Verified email at mayo.edu Cited by 799 |
Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is among the leading causes of worldwide cancer‐related
morbidity and mortality. Poor prognosis of HCC is attributed primarily to tumor presentation …
morbidity and mortality. Poor prognosis of HCC is attributed primarily to tumor presentation …
Application of artificial intelligence for the diagnosis and treatment of liver diseases
Modern medical care produces large volumes of multimodal patient data, which many clinicians
struggle to process and synthesize into actionable knowledge. In recent years, artificial …
struggle to process and synthesize into actionable knowledge. In recent years, artificial …
[PDF][PDF] Inverse association of telomere length with liver disease and mortality in the US population
Physiologic aging leads to attrition of telomeres and replicative senescence. An acceleration
of this process has been hypothesized in the progression of chronic liver disease. We …
of this process has been hypothesized in the progression of chronic liver disease. We …
[HTML][HTML] Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults
Methods The study population included 608,994 adults aged≥ 60 years who underwent
health examinations between 2009 and 2010. Data were collected from the Korean National …
health examinations between 2009 and 2010. Data were collected from the Korean National …
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study
Background & Aims Corticosteroids are the only effective therapy for severe alcohol-associated
hepatitis (AH), defined by a model for end-stage liver disease (MELD) score >20. …
hepatitis (AH), defined by a model for end-stage liver disease (MELD) score >20. …
Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis
Background & Aims Acute-on-chronic liver failure (ACLF) is a syndrome of systemic inflammation
and organ failures. Obesity, also characterized by chronic inflammation, is a risk factor …
and organ failures. Obesity, also characterized by chronic inflammation, is a risk factor …
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States
JC Ahn, M Lauzon, M Luu, M Noureddin, W Ayoub… - Hepatology, 2022 - journals.lww.com
Conclusions Immunotherapy was associated with improved OS compared with chemotherapy
in advanced HCC. There are significant disparities in early access to immunotherapy, …
in advanced HCC. There are significant disparities in early access to immunotherapy, …
[HTML][HTML] Deep learning in hepatocellular carcinoma: Current status and future perspectives
Hepatocellular carcinoma (HCC) is among the leading causes of cancer incidence and
death. Despite decades of research and development of new treatment options, the overall …
death. Despite decades of research and development of new treatment options, the overall …
[HTML][HTML] Hepatocellular carcinoma surveillance: current practice and future directions
Hepatocellular carcinoma (HCC) is among the leading causes of cancer incidence and
mortality worldwide. Surveillance of individuals with cirrhosis or other conditions that confer a …
mortality worldwide. Surveillance of individuals with cirrhosis or other conditions that confer a …
Development of the AI-cirrhosis-ECG score: an electrocardiogram-based deep learning model in cirrhosis
METHODS: A review of Mayo Clinic's electronic health records identified 5,212 patients with
advanced cirrhosis≥ 18 years who underwent liver transplantation at the 3 Mayo Clinic …
advanced cirrhosis≥ 18 years who underwent liver transplantation at the 3 Mayo Clinic …